| ACAN | Aggrecan |
| ACTA2 | α-smooth muscle actin |
| AIC | arterial intimal calcification |
| ALP | Alkaline phosphatase |
| AMC | arterial medial calcification |
| APC | Adenomatous polyposis coli |
| BMP | Bone morphogenetic protein |
| CAC | Coronary artery calcification |
| CaN | Calcineurin |
| CHD | Coronary heart disease |
| CK1 | Casein Kinase-1 |
| CKD | Chronic kidney disease |
| COL2A1 | collagen type II alpha |
| CVD | Cardiovascular disease |
| DKK | Dickkopf |
| ECM | Extracellular matrix |
| FGF | Fibroblast growth factor |
| FZD | Frizzled receptor |
| GRb1 | Ginsenoside Rb1 |
| GSK3β | Glycogen synthase kinase 3-β |
| HDAC | Histone deacetylase |
| HFD | High-fat diet |
| IL | Interleukin |
| Kre | Kremen |
| LRP5/6 | Lipoprotein receptor-related protein 5/6 |
| MSC | Mesenchymal stem cells |
| MMP13 | Matrix metalloprotease 13 |
| NF-AT | nuclear factor of activated T-cells |
| NF-κB | kappa-light-chain-enhancer of activated B cells |
| OCN | Osteocalcin |
| OPG | Osteoprotegerin |
| OPN | Osteopontin |
| OSX | Osterix |
| oxLDL | oxidized low density lipoprotein |
| PIT | inorganic phosphate transporter |
| PPARγ | Peroxisome proliferator-activated receptor γ |
| PPRE | PPAR response element |
| RANKL | receptor activator of nuclear factor-κB ligand |
| RUNX2 | Runt-related transcription factor 2 |
| RAAS | Renin angiotensin aldosterone system |
| RXR | Retinoid X receptor |
| sFRP | secreted frizzled receptor protein |
| SOX9 | SRY-box transcription factor 9 |
| T1D | Type 1 Diabetes |
| T2D | Type 2 Diabetes |
| TCF/LEF | T-cell factor/lymphoid enhancer-binding factor |
| TGFβ | Transforming growth factor β |
| TNFα | Tumor necrosis factor α |
| TRAIL | TNF–related apoptosis-inducing ligand |
| VC | Vascular calcification |
| VSMC | Vascular smooth muscle cells |
| WNT | Wingless/Int-1 |